profit from every $100 of sales.
$0$100
eHealth
$0.46-0.48% today
-89.0% in 1 year
1-year low $0.451-year high $5.08
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $0.37 for every $1 of profit it makes in a year.
CheapExpensive
Not measured for banks and insurers: deposits and policy reserves count as debt, so the usual debt test says nothing about them.
Money in, money out
What eHealth sold, what it kept, and what it did with the cash.
Sales went from $405 million in 2022 to $554 million in 2025, with $40.0 million of profit last year.
SalesProfit
eHealth vs. similar companies
eHealth grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| eHealth | 0.4× · Cheap | ||
 Marsh & McLennan Companies | 23.7× · Fair price | ||
 Arthur J. Gallagher & | 48.4× · Expensive | ||
 Aon | 19.3× · Fair price | ||
 Ryan Specialty Holdings | 187.4× · Very expensive |
AI analysis
An AI analyst reads eHealth's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 405 | 453 | 532 | 554 | |
| 404 | 451 | 531 | – | |
| -83 | -29 | 33 | 68 | |
| -78 | 0 | 47 | 83 | |
| -89 | -28 | 10 | 40 | |
| -4.36 | -2.37 | -1.19 | -0.34 | |
| 99.6% | 99.6% | 99.7% | – | |
| -20.5% | -6.4% | 6.2% | 12.4% | |
| -21.9% | -6.2% | 1.9% | 7.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,113 | 1,113 | 1,155 | 1,262 |
| Cash | 144 | 116 | 39 | 74 |
| Total debt | 107 | 103 | 97 | 134 |
| Total liabilities | 462 | 507 | 567 | 671 |
| 651 | 606 | 588 | 592 | |
| 27 | 28 | 29 | 30 | |
| -10.3% | -2.2% | 3.5% | 7.6% | |
| -13.6% | -4.7% | 1.7% | 6.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -27 | -7 | -18 | -25 | |
| 16 | 11 | 13 | 15 | |
| -42 | -17 | -31 | -41 | |
| Dividends paid | 0 | 4 | 6 | 6 |
| 3 | 3 | 3 | 2 | |
| 20 | 23 | 20 | 15 |
This is a bank or insurer, so cash-flow and debt ratios are left out: borrowing and lending is the business itself. Price to book and return on equity are the measures that matter here.
Valuation
- 0.4×
- 0.6×
- –
- 0.0×
- 0.0×
- 271.0%
- 0.0%
Profitability
- 7.2%
- 7.8%
- -0.4%
- 2.4%
- 1.7%
Growth
- +11.0%
- –
- –
- +3.7%
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 35%of 748
Bottom 32%of 603
Top 1%of 873
Top 44%of 883
What analysts expect
- Average price target
- $3.00
- Range
- $3.00 – $3.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | -0.30 | -0.13 | −137.5% |
| Feb 25, 2026 | 2.17 | 2.38 | −8.8% |
| Nov 5, 2025 | -1.32 | -0.93 | −41.9% |
| Aug 6, 2025 | -0.98 | -0.87 | −12.6% |
| May 7, 2025 | -0.08 | -0.41 | +80.5% |
| Feb 26, 2025 | 2.32 | 2.00 | +16.0% |
| Nov 6, 2024 | -1.86 | -1.13 | −64.6% |
| Aug 7, 2024 | -1.09 | -0.71 | −53.5% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
54No pass
Benjamin Graham
83Pass
Philip Fisher
47No pass
Peter Lynch
59No pass
Joel Greenblatt
53No pass
Charlie Munger
38No pass
Terry Smith
34No pass
Questions about eHealth
Is eHealth a good stock to buy?
A business with weak numbers, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the eHealth AI analysis
What does eHealth do?
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. It operates in two segments, Medicare; and Employer and Individual. It is in Insurance Brokers.
Does eHealth pay a dividend?
Yes. In 2025 it paid out $5.90 million in dividends.
Is eHealth stock halal?
No. eHealth does not pass our halal screen: its debt is 909% of its market value, at or above the 33% limit. How we check
How has eHealth stock done over the past year?
Down 89.0% over the past twelve months, to $0.46. It traded between $0.45 and $5.08 and is 91.0% below its high.
Who are eHealth's competitors?
The largest listed companies in the same industry are Marsh & McLennan Companies, Arthur J. Gallagher &, Aon and Ryan Specialty Holdings. The peers table on this page compares their profit, growth and price with eHealth's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.